ReviewDiagnostic and prognostic research2026

Protocol for the development and validation of a risk score to predict risk of adverse events associated with systemic anti-cancer treatment in late-stage lung cancer: Lung Cancer Improved Decisions (LUCID).

Ofran Almossawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.